ASTELLAS
Astellas Pharma Canada, Inc. is a Canadian affiliate of Tokyo-based Astellas Pharma Inc., a pharmaceutical company conducting business in more than 70 countries around the world.
At Astellas, we strive to become a cutting-edge, value-driven life science innovator. This means working at the forefront of healthcare change to turn innovative science into VALUE for patients. What sets us apart is our focus on patients, our pioneering innovation, our collaborative culture, and the passion of our talented people.
Making a positive impact on patients’ lives is the purpose behind everything we do. At Astellas, we are relentless in our pursuit of scientific progress and in tackling unmet medical needs, demonstrated by our legacy in oncology, overactive bladder, and transplant and our impressive pipeline in women's health and retinal diseases. Astellas’ commitment to patients includes leading-edge research in, immuno-oncology, genetic regulation, mitochondrial and targeted protein degradation approaches to deliver potentially life-changing treatments.
LEARN MORE:
Website: https://www.astellas.com/ca/
MENOPAUSE HEALTH RESOURCES
RESOURCES FOR EMPLOYERS
GROUNDBREAKING REPORTS
ASTRAZENECA
AstraZeneca is a global, innovation-driven biopharmaceutical business with a focus on the discovery, development, and commercialization of medicines that transform lives, with a core scientific focus in the areas of Cardiovascular, Renal and Metabolic (CVRM) disease; Oncology; Rare Disease; Respiratory & Immunology; and Vaccine & Immune Therapies. AstraZeneca operates in more than 100 countries and its innovative medicines are used by millions of patients worldwide.
AstraZeneca employs more than 1,650 employees across Canada, including 800 employees at our Mississauga, Ontario head office and R&D hubs. The company is one of Canada’s leading R&D contributors, investing $148 million in Canadian R&D in 2022. The company has been recognized as one of Canada’s Top 100 Employers 2024, one of Canada’s 10 Most Admired Corporate Cultures 2024, and has been designated a Top Employer in the GTA for 10 consecutive years.
LEARN MORE:
Website: www.astrazeneca.ca
EISAI
At Eisai Canada, we believe patients and their families come first and we have a responsibility to listen to and learn from them. We call this human health care or hhc. We’re on a mission to improve human health care in oncology and neurology, where tough challenges and treatment gaps persist. Eisai Canada is powered by the strength of our global leadership and innovation, harnessing science and the support of partnerships to discover and deliver medicines that matter to people living with cancer, epilepsy, insomnia and Alzheimer’s Disease. We have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai Canada is determined to improve the lives of patients, their families and caregivers.
Established in 1941, Tokyo-based Eisai Co. has over 80 years of history and innovation as a leading global research and development-based pharmaceutical company. With an industry-leading pipeline in oncology and neurology, Eisai Co. has established more than 40 global subsidiaries, opening Eisai Canada in 2011.
LEARN MORE:
Website: https://ca.eisai.com/en-CA
Plan Member Point of View
DOWNLOAD PDF RESOURCE
DOWNLOAD PDF RESOURCE (FR)
Alzheimer’s disease: Impact on the workplace
DOWNLOAD PDF RESOURCE
DOWNLOAD PDF RESOURCE (FR)
MERCK
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases.
Chez Merck, connue sous le nom de MSD à l’extérieur des États-Unis et du Canada, nous sommes unis autour de notre raison d’être : nous utilisons la puissance des méthodes scientifiques de pointe pour sauver des vies et en améliorer partout dans le monde. Depuis plus d’un siècle, nous sommes à l’avant-garde des recherches, produisant des médicaments, des vaccins et des solutions de santé novatrices pour les maladies les plus éprouvantes au monde.
LEARN MORE:
Website: www.merck.ca
LinkedIn: Merck Canada
YouTube: Merck Canada
Twitter: @MerckCanada
PFIZER
Pfizer Canada ULC is the Canadian operation of Pfizer Inc., one of the world's leading biopharmaceutical companies. Our diversified health care portfolio includes some of the world’s best known and most prescribed medicines and vaccines. Pfizer’s ongoing research and development activities focus on a wide range of therapeutic areas following our guiding purpose: Breakthroughs that change patients’ livesTM.
LEARN MORE:
Website: pfizer.ca
LinkedIn: Pfizer
Facebook: Pfizer Canada
Twitter: @PfizerCA
Youtube: Pfizer Canada
CONTACT INFORMATION:
Sarah Nguyen, senior manager, private sector access
sarah.nguyen@pfizer.com
DOWNLOAD PDF RESOURCE
SUN LIFE
Sun Life is a leading international financial services organization providing insurance, wealth and asset management solutions to individual and corporate Clients. Sun Life has operations in a number of markets worldwide, including Canada, the United States, the United Kingdom, Ireland, Hong Kong, the Philippines, Japan, Indonesia, India, China, Australia, Singapore, Vietnam, Malaysia and Bermuda. As of September 30, 2021, Sun Life had total assets under management of $1.39 trillion.
Sun Life Financial Inc. trades on the Toronto (TSX), New York (NYSE) and Philippine (PSE) stock exchanges under the ticker symbol SLF.
À propos de la Sun Life
La Sun Life est une organisation de services financiers internationale de premier plan qui offre aux particuliers et aux entreprises des solutions dans les domaines de l’assurance et de la gestion d’actifs et de patrimoine. Elle exerce ses activités dans divers marchés du monde, soit au Canada, aux États-Unis, au Royaume-Uni, en Irlande, à Hong Kong, aux Philippines, au Japon, en Indonésie, en Inde, en Chine, en Australie, à Singapour, au Vietnam, en Malaisie et aux Bermudes. Au 30 septembre 2021, l’actif total géré de la Sun Life s’élevait à 1 390 milliards de dollars.
Les actions de la Financière Sun Life inc. sont inscrites à la Bourse de Toronto (TSX), à la Bourse de New York (NYSE) et à la Bourse des Philippines (PSE) sous le symbole « SLF ».
LEARN MORE:
Website: www.sunlife.com
Facebook: @SLFCanada
Twitter: @SunLifeCA
LinkedIn: @Sun Life
Instagram: @sunlifeca
Pinterest: @SunLifeCA
YouTube: @Sun Life Canada
DOWNLOAD PDF RESOURCE
TAKEDA
Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines.
Takeda Canada Inc. is the Canadian organization of Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK), a global, values-based, R\&D-driven biopharmaceutical leader headquartered in Japan, committed to discovering and delivering life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R\&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R\&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R\&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions.
À propos de Takeda Canada Inc.
Takeda Canada Inc. est la filiale canadienne de Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE : TAK), chef de file mondial du secteur biopharmaceutique, fondé sur des valeurs et spécialisé en recherche et développement, dont le siège social est au Japon. Nous sommes déterminés à découvrir et à offrir des traitements susceptibles de transformer la vie des patients. Nous sommes guidés par notre engagement envers les patients, nos employés et la planète. Takeda concentre ses efforts de recherche et développement dans quatre domaines thérapeutiques : l’oncologie, les maladies génétiques et hématologiques rares, les neurosciences et la gastroentérologie. Nous effectuons aussi des investissements ciblés pour la recherche et le développement de traitements dans les thérapies à base de plasma et les vaccins. Nous nous concentrons sur le développement de médicaments des plus novateurs qui contribuent à faire la différence dans la vie des patients, en repoussant les limites des nouvelles options thérapeutiques et en tirant profit de notre moteur de R et D collaboratif et de nos capacités pour créer une solide gamme de produits combinant plusieurs modalités de traitement. Nos employés sont déterminés à améliorer la qualité de vie des patients et à travailler avec nos partenaires dans le secteur de la santé dans environ 80 pays et régions.
LEARN MORE:
Website: takeda.com/en-ca
LinkedIn: Takeda